Literature DB >> 2144349

A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line.

K E Willard-Gallo1, F Van de Keere, R Kettmann.   

Abstract

Sequential effects on cellular protein expression following human immunodeficiency virus (type 1) infection of a CD4+ T-cell line in vitro were investigated. Events in the human interleukin 2-dependent helper T-cell line WE17/10 are similar in several respects to the clinical progression in acquired immunodeficiency syndrome. WE17/10 cell infection is characterized by an extended period during which viral replication occurs without accompanying cytotoxicity and with a maximum 30% decrease in surface CD4. Cellular protein expression generally remains unaffected during this first phase of infection. However, after 2-3 months, a severe defect in the expression of the T-cell receptor/CD3 complex both on the cell surface and inside the cell becomes apparent. Other cell membrane markers, such as CD2 and CD25, remain constant throughout the course of infection; after its initial decrease, CD4 remains at 70% of control values. Lack of surface expression of the TCR/CD3 complex is correlated with a specific defect in transcription of the CD3 gamma-chain gene.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144349      PMCID: PMC54607          DOI: 10.1073/pnas.87.17.6713

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Analysis of human lymphocyte protein expression. I. Identification of subpopulation markers by two-dimensional polyacrylamide gel electrophoresis.

Authors:  K E Willard-Gallo; D W Houck; M R Loken
Journal:  Eur J Immunol       Date:  1988-09       Impact factor: 5.532

2.  Signaling through T lymphocyte surface proteins, TCR/CD3 and CD28, activates the HIV-1 long terminal repeat.

Authors:  S E Tong-Starkesen; P A Luciw; B M Peterlin
Journal:  J Immunol       Date:  1989-01-15       Impact factor: 5.422

3.  Human T cell leukemia/lymphoma virus type I infection of a CD4+ proliferative/cytotoxic T cell clone progresses in at least two distinct phases based on changes in function and phenotype of the infected cells.

Authors:  H Yssel; R de Waal Malefyt; M D Duc Dodon; D Blanchard; L Gazzolo; J E de Vries; H Spits
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

4.  Unexpectedly high levels of HIV-1 RNA and protein synthesis in a cytocidal infection.

Authors:  M Somasundaran; H L Robinson
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

Review 5.  Mysteries of HIV: challenges for therapy and prevention.

Authors:  J A Levy
Journal:  Nature       Date:  1988-06-09       Impact factor: 49.962

6.  The biosynthesis and assembly of T cell receptor alpha- and beta-chains with the CD3 complex.

Authors:  F Koning; A M Lew; W L Maloy; R Valas; J E Coligan
Journal:  J Immunol       Date:  1988-05-01       Impact factor: 5.422

7.  HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.

Authors:  B Hofmann; K D Jakobsen; N Odum; E Dickmeiss; P Platz; L P Ryder; C Pedersen; L Mathiesen; I B Bygbjerg; V Faber
Journal:  J Immunol       Date:  1989-03-15       Impact factor: 5.422

8.  Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex.

Authors:  J J Sussman; J S Bonifacino; J Lippincott-Schwartz; A M Weissman; T Saito; R D Klausner; J D Ashwell
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

9.  HIV-1-infected T cells show a selective signaling defect after perturbation of CD3/antigen receptor.

Authors:  G P Linette; R J Hartzman; J A Ledbetter; C H June
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

10.  Selective degradation of T cell antigen receptor chains retained in a pre-Golgi compartment.

Authors:  C Chen; J S Bonifacino; L C Yuan; R D Klausner
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  10 in total

1.  The cytoplasmic domain of the HIV-1 glycoprotein gp41 induces NF-κB activation through TGF-β-activated kinase 1.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  Cell Host Microbe       Date:  2012-02-16       Impact factor: 21.023

2.  The immunosuppressant rapamycin represses human immunodeficiency virus type 1 replication.

Authors:  Jocelyn Roy; Jean-Sébastien Paquette; Jean-François Fortin; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.

Authors:  I Segura; C Delmelle-Wibaut; M Janssens; Y Cleuter; A van den Broeke; R Kettmann; K E Willard-Gallo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

4.  Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule.

Authors:  P Bérubé; B Barbeau; R Cantin; R P Sékaly; M Tremblay
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

5.  Evidence for gene expression by unintegrated human immunodeficiency virus type 1 DNA species.

Authors:  Audrey Brussel; Pierre Sonigo
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Modulation of human immunodeficiency virus type 1-induced syncytium formation by the conformational state of LFA-1 determined by a new luciferase-based syncytium quantitative assay.

Authors:  B Barbeau; J F Fortin; N Genois; M J Tremblay
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

7.  Detection of CD4+ T cells harboring human immunodeficiency virus type 1 DNA by flow cytometry using simultaneous immunophenotyping and PCR-driven in situ hybridization: evidence of epitope masking of the CD4 cell surface molecule in vivo.

Authors:  B K Patterson; C Goolsby; V Hodara; K L Lohman; S M Wolinsky
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

8.  The CD3 versus CD7 plot in multicolor flow cytometry reflects progression of disease stage in patients infected with HTLV-I.

Authors:  Seiichiro Kobayashi; Yamin Tian; Nobuhiro Ohno; Koichiro Yuji; Tomohiro Ishigaki; Masamichi Isobe; Mayuko Tsuda; Naoki Oyaizu; Eri Watanabe; Nobukazu Watanabe; Kenzaburo Tani; Arinobu Tojo; Kaoru Uchimaru
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

9.  Functional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.

Authors:  P Vandenabeele; W Declercq; D Vercammen; M Van de Craen; J Grooten; H Loetscher; M Brockhaus; W Lesslauer; W Fiers
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing.

Authors:  Haidar Akl; Bassam Badran; Gratiela Dobirta; Germain Manfouo-Foutsop; Maria Moschitta; Makram Merimi; Arsène Burny; Philippe Martiat; Karen E Willard-Gallo
Journal:  Virol J       Date:  2007-09-06       Impact factor: 4.099

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.